<DOC>
	<DOC>NCT03042260</DOC>
	<brief_summary>The purpose of this study is to determine whether trimethoprim/sulfamethoxazole is effective in preventing serious infectious complications (those that require hospitalization or lead to death) in patients with lupus erythematosus that receive intermediate or high dose steroids.</brief_summary>
	<brief_title>Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Systemic Lupus Erythematosus according to the American College of Rheumatology Criteria On a daily dose of corticosteroid of â‰¥ 0.5 mg/kg/d, and that are expected to remain on the this dose for at least 1 month. Have signed an informed consent Absolute contraindication to receive TMPSMX (known allergy to TMPSMX or sulfa drugs; TMPSMX induced thrombocytopenia) Received TMPSMX treatment in the previous month The presence of concomitant rheumatologic autoimmune disease with the exception of antiphospholipid syndrome Creatinine clearance &lt;30ml/min/m2 Chronic viral infection (Hepatitis C virus, Hepatitis B virus, Human immunodeficiency virus) Malignant neoplasm, except for skin neoplasm Primary immune deficiencies Solid organ or hematopoietic stem cell transplant recipients Pregnancy or Breastfeeding Current active infection or in the 2 weeks prior. Absolute Neutrophil Count &lt; 750/mm3, platelets &lt;30x10^9/L, o hemoglobin &lt;8 g/dL Patients receiving Methotrexate Patients participating in another research study that to the judgement of the principal investigator could jeopardize the safety or efficacy of the study drug.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>trimethoprim, sulfamethoxazole drug combination</keyword>
	<keyword>Infection</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>